BuCE Versus BuME as Conditioning Therapy in Non-Hodgkin's Lymphoma

busulfan 3.2 mg/kg/day i.v. on days -8,-7, and -6

cyclophosphamide 50mg/kg/day i.v. on days -3 and -2

etoposide 400mg/m2 day i.v. on days -5 and -4

melphalan 50mg/m2/day i.v. on days -3 and -2